Cardiac allograft vasculopathy (CAV): 10-year results of a randomized trial comparing tacrolimus versus cyclosporine in combination with mycophenolate mofetil after heart transplantation

Thoracic and Cardiovascular Surgeon(2012)

Cited 0|Views9
No score
Abstract
Objectives: Cardiac allograft vasculopathy (CAV) is a major cause of long-term mortality after heart transplantation. Long-term results of prospective randomized trials in this context are scarce.
More
Translated text
Key words
Allograft Vasculopathy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined